Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Jan;64(1):18–24. doi: 10.1136/jnnp.64.1.18

Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease

J Bowler 1, D Munoz 1, H Merskey 1, V Hachinski 1
PMCID: PMC2169908  PMID: 9436722

Abstract

OBJECTIVE—Necropsy confirmed clinical diagnostic accuracy for Alzheimer's disease is claimed to exceed 90%. This figure contains two fallacies; it includes cases in which Alzheimer's disease exists with other diseases affecting cognition and the studies that report these figures excluded cases without necropsy (verification bias). The effect of these errors is estimated.
METHODS—Data were taken from the University of Western Ontario Dementia Study, a registry of dementia cases with clinical and psychometric follow up to necropsy based in a university memory disorders clinic with secondary and tertiary referrals. Data were available on 307 patients; 200 (65%) had clinically diagnosed Alzheimer's disease, 12 (4%) vascular dementia, 47 (15%) mixed dementia, and 48 (16%) had other diagnoses. One hundred and ninety two of 307 cases (63%) died and 122 of 192 fatalities (64%) had necropsies. The pathological material was interpreted in two ways, allowing and disallowing coexistent disease in making a diagnosis of Alzheimer's disease. In cases without necropsy, progressive cognitive loss was used as a marker for degenerative dementia. The outcome measures of interest were the positive predictive value of a clinical diagnosis of Alzheimer's disease allowing and disallowing coexistent diseases and with and without correction for cases that were not necropsied.
RESULTS—The clinical diagnoses differed significantly between the population who died and those who did not. In cases without necropsy, 22% had no dementia on follow up, concentrated in early cases and men, showing considerable scope for verification bias. The positive predictive value of a diagnosis of Alzheimer's disease was 81% including coexistent diseases, falling to 44% when limited to pure cases. Combined, these factors reduce the positive predictive value to 38% for pure Alzheimer's disease.
CONCLUSIONS—Correction for dual pathology and verification bias halves the positive predictive value of the clinical diagnosis of Alzheimer's disease. Data derived from necropsy studies cannot be extrapolated to the whole population. This has important implications including uncertainty about diagnosis and prognosis and a dilution effect in therapeutic trials in Alzheimer's disease.



Full Text

The Full Text of this article is available as a PDF (119.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen K., Launer L. J., Ott A., Hoes A. W., Breteler M. M., Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology. 1995 Aug;45(8):1441–1445. doi: 10.1212/wnl.45.8.1441. [DOI] [PubMed] [Google Scholar]
  2. Becker J. T., Boller F., Lopez O. L., Saxton J., McGonigle K. L. The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis. Arch Neurol. 1994 Jun;51(6):585–594. doi: 10.1001/archneur.1994.00540180063015. [DOI] [PubMed] [Google Scholar]
  3. Begg C. B., Greenes R. A. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics. 1983 Mar;39(1):207–215. [PubMed] [Google Scholar]
  4. Bowler J. V., Eliasziw M., Steenhuis R., Munoz D. G., Fry R., Merskey H., Hachinski V. C. Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia. Arch Neurol. 1997 Jun;54(6):697–703. doi: 10.1001/archneur.1997.00550180021007. [DOI] [PubMed] [Google Scholar]
  5. Breitner J. C., Gau B. A., Welsh K. A., Plassman B. L., McDonald W. M., Helms M. J., Anthony J. C. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 1994 Feb;44(2):227–232. doi: 10.1212/wnl.44.2.227. [DOI] [PubMed] [Google Scholar]
  6. Corbett A., Bennett H., Kos S. Cognitive dysfunction following subcortical infarction. Arch Neurol. 1994 Oct;51(10):999–1007. doi: 10.1001/archneur.1994.00540220045013. [DOI] [PubMed] [Google Scholar]
  7. Del-Ser T., Munoz D. G., Hachinski V. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology. 1996 Mar;46(3):682–686. doi: 10.1212/wnl.46.3.682. [DOI] [PubMed] [Google Scholar]
  8. Erkinjuntti T., Haltia M., Palo J., Sulkava R., Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry. 1988 Aug;51(8):1037–1044. doi: 10.1136/jnnp.51.8.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Förstl H., Burns A., Luthert P., Cairns N., Levy R. The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry. 1993 Mar;162:385–392. doi: 10.1192/bjp.162.3.385. [DOI] [PubMed] [Google Scholar]
  10. Gearing M., Mirra S. S., Hedreen J. C., Sumi S. M., Hansen L. A., Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology. 1995 Mar;45(3 Pt 1):461–466. doi: 10.1212/wnl.45.3.461. [DOI] [PubMed] [Google Scholar]
  11. Gibb W. R., Esiri M. M., Lees A. J. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain. 1987 Oct;110(Pt 5):1131–1153. doi: 10.1093/brain/110.5.1131. [DOI] [PubMed] [Google Scholar]
  12. Gorelick P. B., Chatterjee A., Patel D., Flowerdew G., Dollear W., Taber J., Harris Y. Cranial computed tomographic observations in multi-infarct dementia. A controlled study. Stroke. 1992 Jun;23(6):804–811. doi: 10.1161/01.str.23.6.804. [DOI] [PubMed] [Google Scholar]
  13. Hansen L., Salmon D., Galasko D., Masliah E., Katzman R., DeTeresa R., Thal L., Pay M. M., Hofstetter R., Klauber M. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 1990 Jan;40(1):1–8. doi: 10.1212/wnl.40.1.1. [DOI] [PubMed] [Google Scholar]
  14. Helmes E., Merskey H., Fox H., Fry R. N., Bowler J. V., Hachinski V. C. Patterns of deterioration in senile dementia of the Alzheimer type. Arch Neurol. 1995 Mar;52(3):306–310. doi: 10.1001/archneur.1995.00540270102026. [DOI] [PubMed] [Google Scholar]
  15. Helmes E., Merskey H., Hachinski V. C., Wands K. An examination of psychometric properties of the extended scale for dementia in three different populations. Alzheimer Dis Assoc Disord. 1992 Winter;6(4):236–246. doi: 10.1097/00002093-199206040-00005. [DOI] [PubMed] [Google Scholar]
  16. Hersch E. L. Development and application of the extended scale for dementia. J Am Geriatr Soc. 1979 Aug;27(8):348–354. doi: 10.1111/j.1532-5415.1979.tb06056.x. [DOI] [PubMed] [Google Scholar]
  17. Hunink M. G., Polak J. F., Barlan M. M., O'Leary D. H. Detection and quantification of carotid artery stenosis: efficacy of various Doppler velocity parameters. AJR Am J Roentgenol. 1993 Mar;160(3):619–625. doi: 10.2214/ajr.160.3.8430567. [DOI] [PubMed] [Google Scholar]
  18. Joachim C. L., Morris J. H., Selkoe D. J. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol. 1988 Jul;24(1):50–56. doi: 10.1002/ana.410240110. [DOI] [PubMed] [Google Scholar]
  19. Khachaturian Z. S. Diagnosis of Alzheimer's disease. Arch Neurol. 1985 Nov;42(11):1097–1105. doi: 10.1001/archneur.1985.04060100083029. [DOI] [PubMed] [Google Scholar]
  20. Kukull W. A., Larson E. B., Reifler B. V., Lampe T. H., Yerby M. S., Hughes J. P. The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology. 1990 Sep;40(9):1364–1369. doi: 10.1212/wnl.40.9.1364. [DOI] [PubMed] [Google Scholar]
  21. Lau C., Wands K., Merskey H., Boniferro M., Carriere L., Fox H., Hachinski V. C. Sensitivity and specificity of the extended scale for dementia. Arch Neurol. 1988 Aug;45(8):849–852. doi: 10.1001/archneur.1988.00520320035012. [DOI] [PubMed] [Google Scholar]
  22. Lennox G., Lowe J., Landon M., Byrne E. J., Mayer R. J., Godwin-Austen R. B. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry. 1989 Nov;52(11):1236–1247. doi: 10.1136/jnnp.52.11.1236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Liu C. K., Miller B. L., Cummings J. L., Mehringer C. M., Goldberg M. A., Howng S. L., Benson D. F. A quantitative MRI study of vascular dementia. Neurology. 1992 Jan;42(1):138–143. doi: 10.1212/wnl.42.1.138. [DOI] [PubMed] [Google Scholar]
  24. Loeb C., Gandolfo C., Bino G. Intellectual impairment and cerebral lesions in multiple cerebral infarcts. A clinical-computed tomography study. Stroke. 1988 May;19(5):560–565. doi: 10.1161/01.str.19.5.560. [DOI] [PubMed] [Google Scholar]
  25. McGeer P. L., Schulzer M., McGeer E. G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 1996 Aug;47(2):425–432. doi: 10.1212/wnl.47.2.425. [DOI] [PubMed] [Google Scholar]
  26. McKeith I., Fairbairn A., Perry R., Thompson P., Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ. 1992 Sep 19;305(6855):673–678. doi: 10.1136/bmj.305.6855.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  28. Mendez M. F., Mastri A. R., Sung J. H., Frey W. H., 2nd Clinically diagnosed Alzheimer disease: neuropathologic findings in 650 cases. Alzheimer Dis Assoc Disord. 1992 Spring;6(1):35–43. doi: 10.1097/00002093-199205000-00004. [DOI] [PubMed] [Google Scholar]
  29. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991 Apr;41(4):479–486. doi: 10.1212/wnl.41.4.479. [DOI] [PubMed] [Google Scholar]
  30. Morris J. C., McKeel D. W., Jr, Fulling K., Torack R. M., Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol. 1988 Jul;24(1):17–22. doi: 10.1002/ana.410240105. [DOI] [PubMed] [Google Scholar]
  31. Mölsä P. K., Paljärvi L., Rinne J. O., Rinne U. K., Säkö E. Validity of clinical diagnosis in dementia: a prospective clinicopathological study. J Neurol Neurosurg Psychiatry. 1985 Nov;48(11):1085–1090. doi: 10.1136/jnnp.48.11.1085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. O'Brien M. D. Vascular dementia is underdiagnosed. Arch Neurol. 1988 Jul;45(7):797–798. doi: 10.1001/archneur.1988.00520310115025. [DOI] [PubMed] [Google Scholar]
  33. Perry R. H., Irving D., Blessed G., Fairbairn A., Perry E. K. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci. 1990 Feb;95(2):119–139. doi: 10.1016/0022-510x(90)90236-g. [DOI] [PubMed] [Google Scholar]
  34. Ransohoff D. F., Feinstein A. R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978 Oct 26;299(17):926–930. doi: 10.1056/NEJM197810262991705. [DOI] [PubMed] [Google Scholar]
  35. Rich J. B., Rasmusson D. X., Folstein M. F., Carson K. A., Kawas C., Brandt J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology. 1995 Jan;45(1):51–55. doi: 10.1212/wnl.45.1.51. [DOI] [PubMed] [Google Scholar]
  36. Sulkava R., Haltia M., Paetau A., Wikström J., Palo J. Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry. 1983 Jan;46(1):9–13. doi: 10.1136/jnnp.46.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tierney M. C., Fisher R. H., Lewis A. J., Zorzitto M. L., Snow W. G., Reid D. W., Nieuwstraten P. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology. 1988 Mar;38(3):359–364. doi: 10.1212/wnl.38.3.359. [DOI] [PubMed] [Google Scholar]
  38. Tomlinson B. E., Blessed G., Roth M. Observations on the brains of demented old people. J Neurol Sci. 1970 Sep;11(3):205–242. doi: 10.1016/0022-510x(70)90063-8. [DOI] [PubMed] [Google Scholar]
  39. Wade J. P., Mirsen T. R., Hachinski V. C., Fisman M., Lau C., Merskey H. The clinical diagnosis of Alzheimer's disease. Arch Neurol. 1987 Jan;44(1):24–29. doi: 10.1001/archneur.1987.00520130016010. [DOI] [PubMed] [Google Scholar]
  40. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]
  41. del Ser T., Bermejo F., Portera A., Arredondo J. M., Bouras C., Constantinidis J. Vascular dementia. A clinicopathological study. J Neurol Sci. 1990 Apr;96(1):1–17. doi: 10.1016/0022-510x(90)90052-o. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES